Back to NVSView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA6/20/2019
Trecondi
Treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (alloHSCT) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
View on EMADrug Science
Mechanism of action & safety profile
Related Pipeline
Peg-alpha interferon (Peg-Intron)Phase 3
Leukemia, Myeloid, Chronic
cyclosporin + mycophenolate mofetilPhase 3
Kidney Failure
Imatinib Mesylate (Gleevec)Phase 3
Idiopathic Pulmonary Fibrosis
GP2017 (adalimumab biosimilar)Phase 3
Ankylosing Spondylitis
Nilotinib (Tasigna ®)Phase 3
Chronic Myeloid Leukemia
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts